Cargando…
The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process
All medicinal products authorized in the European Union are subjects of constant drug-safety monitoring processes. It is organized in a pharmacovigilance system that is designed to protect human health and life by the detection, analysis and prevention of adverse drug reactions (ADRs) and other drug...
Autores principales: | Sienkiewicz, Kamila, Burzyńska, Monika, Rydlewska-Liszkowska, Izabela, Sienkiewicz, Jacek, Gaszyńska, Ewelina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745009/ https://www.ncbi.nlm.nih.gov/pubmed/35010673 http://dx.doi.org/10.3390/ijerph19010413 |
Ejemplares similares
-
Indirect and Direct 65+ Patient Reporting of Non-Steroidal Anti-Inflammatory Drug-Induced Adverse Drug Reactions as a Source of Information on Polypharmacy and Polypharmacy-Related Risk
por: Sienkiewicz, Kamila, et al.
Publicado: (2023) -
Priority Setting in the Polish Health Care System According to Patients’ Perspective
por: Rybarczyk-Szwajkowska, Anna, et al.
Publicado: (2021) -
Informal Dementia Caregivers: Current Technology Use and Acceptance of Technology in Care
por: Wójcik, Daniel, et al.
Publicado: (2021) -
Influence of CYP2C19*2/*17 genotype on adverse drug reactions of voriconazole in patients after allo-HSCT: a four-case report
por: Beata, Sienkiewicz, et al.
Publicado: (2017) -
Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT
por: Sienkiewicz, Beata, et al.
Publicado: (2017)